SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION
SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION
批准号:
6116114
负责人:
TOSHIAKI KODAMA
金额:
$14.76万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-15 至 2000-04-30
中文摘要
已有文献证明,进行性CD4+ T细胞
英文摘要
It has been well documented that the progressive CD4+ T cell
depletion and development of AIDS are closely associated to an HIV-1
coreceptor switch from CCR5 to CXCR4. The objective of this study is
to investigate the basic mechanisms underlying CD4+ T cell depletion
in AIDS using an SIV animal model system. We have constructed a
cloned SIVmacEvT3 that uses CXCR4 as a coreceptor and rapidly induces
CD4+ T cell depletion in rhesus macaques. In contrast, a cloned
SIVmac239 that uses CCR5 does not induce CD4+ T cell depletion. The
differences of coreceptor usage and pathogenic potential between EvT3
and 239 are determined by the gp120 sequences. In this study, we are
investigating the basic mechanisms by which SIV CXCR4 usage
contributes to CD4+ T cell depletion in vivo. In Year 1 of this
grant, we established an RT-PCR method that quantitatively detects
mRNA of CXCR4, CCR5 that function as coreceptors for EvT3 and 239,
respectively. We found that CXCR4 was consistently expressed in
rhesus CD4+ T cells at high levels in both resting and activated
cells, whereas CCR5 expression was restricted to activated cells.
This strongly suggests that the CXCR4 usage of EvT3 would facilitate
infection of CD4+ T cells regardless of their activation status. We
are currently investigating whether the SIV coreceptor usages coupled
with the expression of coreceptors in CD4+ T cells determines the
susceptibility of CD4+ T cells to SIV infection in both in vitro and
in vivo systems. While EvT3 uses CXCR4 and induces CD4+ T cell
depletion, it is not clear whether the CXCR4 usage is responsible for
the CD4+ T cell depletion or other viral factor(s) in EvT3 gp120
contributes to the CD4+ T cell depletion. To identify genetic
determinant(s) for CXCR4 use and pathogenic poten tial of EvT3, we
constructed various recombinants and site-specific mutant viruses.
Our data demonstrated that the EvT3 CXCR4 usage in vitro was primarily
determined by the V3 sequences. However, preliminary data suggested
that, in addition to the CXCR4 usage, an unidentified viral factor in
EvT3 gp120 was required for the induction of CD4+ T cell depletion in
vivo. Further studies will be warranted to understand the basic
mechanisms underlying CD4+ T cell depletion and the role of viral
coreceptor usage in the pathological event. The rhesus macaque model
using the molecularly cloned SIV with a defined viral sequence,
coreceptor usage and pathogenic potential will greatly contribute to
better understanding of the significance of HIV-1 coreceptor usages
for CD4+ T cell depletion in AIDS patients. This study will also
potentially provide useful information for development of novel
antiviral strategies that target to block the use of coreceptors by
HIV-1. FUNDING NIH AI42508 PUBLICATIONS Martin K, Hagen S, Kodama T.
Genetic determinants of SIV CXCR4 usage the role of V1 and V3
sequences. In 16th Annual Symposium on Nonhuman Primate Models for
AIDS (held in Atlanta, GA, October 7-10, 1998) (abstract 3).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION
-
批准号:6592292
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV
-
批准号:6592291
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV
-
批准号:6453667
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION
-
批准号:6453668
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
Pathogenic Conversion of Attenuated SIV D nef
-
批准号:6632497
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
Pathogenic Conversion of Attenuated SIV D nef
-
批准号:6747336
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
Pathogenic Conversion of Attenuated SIV D nef
-
批准号:6408006
-
项目类别:
-
资助金额:$31.31万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
Pathogenic Conversion of Attenuated SIV D nef
-
批准号:6511643
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV
-
批准号:6116113
-
项目类别:
-
资助金额:$14.76万
-
财政年份:1999
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIGNIFICANCE OF SIV CELL SPECIFICITY FOR AIDS DISEASE PROCESSES
-
批准号:6277345
-
项目类别:
-
资助金额:$18.45万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:2542928
-
项目类别:
-
资助金额:$24.96万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:6399607
-
项目类别:
-
资助金额:$26.46万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:2887674
-
项目类别:
-
资助金额:$25.71万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:6373779
-
项目类别:
-
资助金额:$27.28万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:6510794
-
项目类别:
-
资助金额:$28.02万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:6170760
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGIONS OF SIV
-
批准号:6277346
-
项目类别:
-
资助金额:$18.45万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR BASIS OF SIV NEUROPATHOGENESIS: HIV
-
批准号:6247194
-
项目类别:
-
资助金额:$18.46万
-
财政年份:1997
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIGNIFICANCE OF SIV CELL SPECIFICITY FOR AIDS DISEASE PROCESSES
-
批准号:6247195
-
项目类别:
-
资助金额:$18.46万
-
财政年份:1997
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV: AIDS
-
批准号:6247196
-
项目类别:
-
资助金额:$18.46万
-
财政年份:1997
-
负责人:TOSHIAKI KODAMA
-
依托单位:
海外基金